Pain News and Research

Latest Pain News and Research

Engineering and Physical Sciences Research Council awards £1.2 million to Bilayer Platform project

Scientists at the University of Southampton and Birkbeck College, University of London are developing a platform consisting of an array of artificial cell membranes that will enable more efficient testing of potential new drugs.

23 Jun 2010

Johns Hopkins School of Medicine develops RAALI for healthcare providers

The Johns Hopkins School of Medicine, the nation's leading medical school recipient of research funds from the National Institutes of Health and a recognized center for "Best Practices" by the Accreditation Council for Continuing Medical Education, discussed the development of a unique medical education initiative - the Rheumatoid Arthritis Action Lab Initiative - to give healthcare providers connectivity to much-needed information on rheumatoid arthritis.

23 Jun 2010

Healthcare technology innovation projects to receive $3M in CIMIT medical research grants

A wide variety of early-stage, healthcare technology innovation projects in NeuroHealth, Traumatic Stress Disorders, and integrated clinical environments were among those chosen to receive more than $3 million in CIMIT seed grants for FY11.

23 Jun 2010

REM sleep deprivation leads to changes in levels of key proteins that increase risk of migraine: Study

Reporting at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week, new research shows that sleep deprivation leads to changes in the levels of key proteins that facilitate events involved in the underlying pathology of migraine.

23 Jun 2010

TheraQuest launches new analgesic product pipeline

TheraQuest Biosciences, Inc., a clinical stage pain management company today unveiled its analgesic product pipeline. TheraQuest also announced the launch of its new corporate website at http://www.theraquestinc.com.

23 Jun 2010

Health reform includes changes to denied claims, health savings accounts

News outlets examine some changes to the health care system that health reform will bring, including help for those with denied insurance claims and health savings account modifications.

23 Jun 2010

Methodist surgeons study transvaginal removal of donor kidney

Surgeons at The Methodist Hospital in Houston are studying a new way to make kidney donation safer, less invasive and almost scar free for women by using a new technique that removes kidneys transvaginally.

22 Jun 2010

Protea Biosciences, Mayoly-Spindler commence Phase I/IIA human clinical trial for new recombinant Lipase

Protea Biosciences, Inc., a leading developer of new technology for pharmaceutical research, announced today that the company, in partnership with Mayoly-Spindler, a European pharmaceutical company, has commenced a Phase I/IIA human clinical trial for a new recombinant Lipase.

22 Jun 2010

Enobia reports positive interim data from ENB-0040 enzyme replacement therapy study for children with HPP

Enobia Pharma today announced positive interim data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After 12 weeks of treatment with ENB-0040, children with HPP showed marked improvements in bone mineralization and function including increases in strength, endurance and mobility and reduction in pain. These findings were presented by Dr. Michael Whyte at ENDO 2010, the 92nd Annual Meeting of The Endocrine Society.

22 Jun 2010

Women who experience early menopause may have cardiovascular disease later in life: Study

Women who experience early menopause appear to have more than twice the risk of having a heart attack, stroke or other cardiovascular disease event later in life than do women who do not go through early menopause, a new study indicates. The results will be presented Saturday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Malpractice reformers get grants, but fear of lawsuits remains ER scourge

A New York judge's unusual technique — listening to the families of injured people, knowing something about medicine — for dealing with difficult medical malpractice cases will be among 20 explored with $3 million grants as part of the health overhaul, The Associated Press reports. The judge, Douglas McKeon, said, "I don't discuss settlement offers with families right away. … I just say, 'Tell me a little bit about your loved one.'"

21 Jun 2010

CardioGenics announces clinical test sites for QL Care portable blood analyzer

CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for clinical testing of its patented QL Care™ Analyzer, a portable diagnostic platform designed to produce test results with central lab-like accuracy in 15 minutes using whole blood.

21 Jun 2010

Boston Scientific adds 22 new balloon sizes to PolarCath Peripheral Dilatation System

Boston Scientific Corporation today announced that 22 new balloon sizes have been added to the PolarCath® Peripheral Dilatation System, including balloon lengths of 120 and 150 mm. The PolarCath System is used to restore blood flow in patients with critical limb ischemia (severe blockages in the arteries below the knee) and blockages in the femoral and popliteal (behind the knee) arteries. Both conditions result from peripheral artery disease.

21 Jun 2010

Essen BioScience, Nycomed partner to develop modulators of voltage-gated ion channels

Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services - and Nycomed - a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.

From Sartorius 21 Jun 2010

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant protection in the initial animal survival studies of Dengue virus infection. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley.

21 Jun 2010

OncoGenex initiates Phase 3 Prostate Cancer SATURN Trial

OncoGenex Pharmaceuticals, Inc. announced today the initiation of a Phase 3 registration trial of custirsen sodium (OGX-011/TV-1011), its lead product candidate being developed for the treatment of castrate-resistant prostate cancer (CRPC). This trial, referred to as the Prostate Cancer SATURN Trial, is the first of three Phase 3 trials to be initiated under a global collaboration and license agreement between OncoGenex and Teva Pharmaceutical Industries to develop and commercialize OGX-011/ TV-1011.

21 Jun 2010

Researchers develop new drugs that relieve cancer pain without side effects

Researchers at the University of Leicester and the University of Ferrara in Italy have collaborated to develop new drugs which have the potential to relieve cancer pain without causing many of the side effects of current pain-treatments like morphine.

21 Jun 2010

Beyond Moose and Mountains initiative focuses on building Canada's business and regulatory environment

At its 2010 annual general meeting in Montreal yesterday, the national biotechnology association, BIOTECanada, confirmed a national team of industry leaders, whose expertise will ensure Canada keeps growing what today is an $84 billion bio-economy.

21 Jun 2010

Zydus Cadila receives DCGI approval to initiate Phase I clinical trial for ZYOG1

Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule.

21 Jun 2010

Too much tea raises the risk of rheumatoid arthritis: Study

Rheumatoid arthritis (RA) a severely debilitating inflammatory disease of the joints is on the rise worldwide. It leads to severe pain, stiffness, swelling and loss of movement of joints like knees, wrist and even fingers. RA affects women more than men. RA occurs in people who develop a rogue immune system that attacks the tissue that lines the joint cavities called the synovium leading to degeneration of the joints and the symptoms of the disease. In 1995 36.4 per 100,000 women were diagnosed with RA whereas in 2005 the number rose to 54 per 100,000 women.

20 Jun 2010

Pain News and Research

Latest Pain News and Research

Engineering and Physical Sciences Research Council awards £1.2 million to Bilayer Platform project

Johns Hopkins School of Medicine develops RAALI for healthcare providers

Healthcare technology innovation projects to receive $3M in CIMIT medical research grants

REM sleep deprivation leads to changes in levels of key proteins that increase risk of migraine: Study

TheraQuest launches new analgesic product pipeline

Health reform includes changes to denied claims, health savings accounts

Methodist surgeons study transvaginal removal of donor kidney

Protea Biosciences, Mayoly-Spindler commence Phase I/IIA human clinical trial for new recombinant Lipase

Enobia reports positive interim data from ENB-0040 enzyme replacement therapy study for children with HPP

Women who experience early menopause may have cardiovascular disease later in life: Study

Malpractice reformers get grants, but fear of lawsuits remains ER scourge

CardioGenics announces clinical test sites for QL Care portable blood analyzer

Boston Scientific adds 22 new balloon sizes to PolarCath Peripheral Dilatation System

Essen BioScience, Nycomed partner to develop modulators of voltage-gated ion channels

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

OncoGenex initiates Phase 3 Prostate Cancer SATURN Trial

Researchers develop new drugs that relieve cancer pain without side effects

Beyond Moose and Mountains initiative focuses on building Canada's business and regulatory environment

Zydus Cadila receives DCGI approval to initiate Phase I clinical trial for ZYOG1

Too much tea raises the risk of rheumatoid arthritis: Study

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Pain News and Research

Latest Pain News and Research

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Newsletters you may be interested in